Fenofibrate and Fenofibric acid interaction

Fenofibrate and Fenofibric acid: both prescribing labels flag this combination with the strongest language, such as a contraindication, a boxed warning, or an instruction to avoid it.

Major

Do not combine without a prescriber's guidance. The label language below is the strongest FDA uses.

What the FDA labels say

From the Fenofibrate label · effective 2026-05-12

Major

Hypersensitivity to fenofibrate, fenofibric acid, or any of the excipients in fenofibrate capsules.

Contraindicationsnames Fenofibric acidView label on DailyMed
Major

Hypersensitivity to fenofibrate, fenofibric acid, or any of the excipients in fenofibrate capsules ( 4 )

Contraindicationsnames Fenofibric acidView label on DailyMed
Major

Fenofibrate is contraindicated in patients with a hypersensitivity to fenofibrate, fenofibric acid, or any of the ingredients in fenofibrate capsules.

Warnings and precautionsnames Fenofibric acidView label on DailyMed
Minor

Because of chemical, pharmacological, and clinical similarities between fenofibrates, including fenofibrate; pemafibrate; clofibrate; and gemfibrozil; the findings in 5 large randomized, placebo-controlled clinical trials with these other fibrate drugs may also apply to fenofibrate capsules.

Warnings and precautionsby drug classView label on DailyMed

From the Fenofibric acid label · effective 2025-08-02

Major

Hypersensitivity to fenofibric acid, fenofibrate, or any of the excipients in fenofibric acid delayed-release capsules.

Contraindicationsnames FenofibrateView label on DailyMed
Major

Serious hypersensitivity reactions including anaphylaxis and angioedema have been reported with fenofibrate [see Warnings and Precautions (5.9) ] .

Contraindicationsnames FenofibrateView label on DailyMed
Major

Hypersensitivity to fenofibric acid, fenofibrate, or any of the excipients in fenofibric acid delayed-release capsules ( 4 ).

Contraindicationsnames FenofibrateView label on DailyMed
Major

Hepatotoxicity: Serious drug-induced liver injury, including liver transplantation and death, has been reported with fenofibrates, including fenofibric acid delayed-release capsules.

Warnings and precautionsnames FenofibrateView label on DailyMed
Major

Hepatotoxicity Serious drug-induced liver injury (DILI), including liver transplantation and death, has been reported with postmarketing use of fenofibrates, including fenofibric acid delayed-release capsules.

Warnings and precautionsnames FenofibrateView label on DailyMed

Taking more than these two? Interactions stack. Check your whole list at once; it stays in your browser.

Open in the checker

Not medical advice. Interaction Checker quotes FDA label text and NIH fact sheets. Whether an interaction matters for you depends on doses, timing, kidney and liver function, and other conditions. Confirm with a pharmacist or prescriber.